Marine Derived Drugs (Ether, Peptide, and Phenol) Market Research Report 2022 - Global Forecast to 2027: Increase in Pharmacokinetic Research on Marine-Derived Compounds -

The "Marine Derived Drugs Market Research Report by Type (Ether, Peptide, and Phenol), Source, Mode of Delivery, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to's offering.

The Global Marine Derived Drugs Market size was estimated at USD 10.54 billion in 2021, USD 11.46 billion in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 8.90% to reach USD 17.58 billion by 2027.

In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward.

The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects.

It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Marine Derived Drugs Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others.

Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate.

All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

  • Abbott Laboratories
  • Abbvie Inc
  • Aker BioMarine AS
  • Aphios Corporation
  • Bayer Innovation Marine Polymer Technologies, Inc.
  • GlaxoSmithKline PLC
  • Pharma Marine USA, LLC
  • Sanofi S.A.
  • Sea Run Holdings, Inc.
  • Takeda Oncology's Millennium

Key Topics Covered:

1. Preface

1.1. Objectives of the Study

1.2. Market Segmentation & Coverage

1.3. Years Considered for the Study

1.4. Currency & Pricing

1.5. Language

1.6. Limitations

1.7. Assumptions

1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective

2.2. Determine: Research Design

2.3. Prepare: Research Instrument

2.4. Collect: Data Source

2.5. Analyze: Data Interpretation

2.6. Formulate: Data Verification

2.7. Publish: Research Report

2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics

5.1.1. Drivers High prevalence of unmet medical needs Increasing initiatives for preserving marine biodiversity Rising incidence of chronic ailments

5.1.2. Restraints Complexity in drug development from marine sources due to environmental conditions and microorganisms residing in the marine animal

5.1.3. Opportunities Innovation of pharmaceutical products Advances in cancer therapy and immune signaling Increase in pharmacokinetic research on marine-derived compounds

5.1.4. Challenges Lack of awareness and social taboos commonly associated with advanced medications

5.2. Cumulative Impact of COVID-19

5.3. Cumulative Impact of 2022 Russia Ukraine Conflict

6. Marine Derived Drugs Market, by Type

6.1. Introduction

6.2. Ether

6.3. Peptide

6.4. Phenol

6.5. Steroid

7. Marine Derived Drugs Market, by Source

7.1. Introduction

7.2. Algae

7.3. Invertebrates

7.4. Microorganisms

8. Marine Derived Drugs Market, by Mode of Delivery

8.1. Introduction

8.2. Anti-cardiovascular

8.3. Anti-inflammatory

8.4. Anti-microbial

8.5. Anti-tumor

8.6. Anti-viral

9. Americas Marine Derived Drugs Market

9.1. Introduction

9.2. Argentina

9.3. Brazil

9.4. Canada

9.5. Mexico

9.6. United States

10. Asia-Pacific Marine Derived Drugs Market

11. Europe, Middle East & Africa Marine Derived Drugs Market

12. Competitive Landscape

12.1. FPNV Positioning Matrix

12.2. Market Ranking Analysis

12.3. Market Share Analysis, By Key Player

12.4. Competitive Scenario

13. Company Usability Profiles

For more information about this report visit Marine Derived Drugs Market Research Report by Type (Ether, Peptide, and Phenol), Source, Mode of Delivery, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19